Sector: Healthcare

Small Cap

Avience Biomedicals Share Price

AVIENCE

₹265

13.80(5.49%)

24th Jul 2026 | 3:28 PM

NSE : AVIENCE

Open Free Demat Account

Avience Biomedicals Performance

Price Movement

₹265.00

₹238.00

₹265.00

↘ Today's Low↗ Today's High

1 Year Performance

₹265.00

₹222.00

₹414.95

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹265.00

Low₹238.00

Open at₹245.00

Prev Close₹251.20

Volumes1.69 L

Avg Price₹245.43

Lower Circuit₹201.00

Upper Circuit₹301.40

Historical Performance

3M High₹414.95

3M Low₹222.00

1 Yr High₹414.95

1 Yr Low₹222.00

3 Yr High₹414.95

3 Yr Low₹222.00

5 Yr High₹414.95

5 Yr Low₹222.00

Summary

As of 24-07-2026 05:10, Avience Biomedicals Ltd. share price today is ₹0, with a change of ₹-251.20 (-100.00%) from the previous close of ₹251.2. The stock opened at ₹245 and traded between ₹238 and ₹265, with a total traded volume of 168600 shares. The company has a market capitalization of ₹101.3 Cr in the Healthcare sector. while its 52-week high and low are ₹414.95 and ₹222, respectively.

Avience Biomedicals Ltd. valuation metrics include a P/E ratio of 11.6, EPS of ₹21.71, and book value of ₹3.20. Profitability indicators show ROE of 27.86%.

Avience Biomedicals Ltd. technical indicators include Day RSI at 24.57, Day MFI at 41.58. Additional indicators include Commodity Channel Index (CCI) at -82.5 and Williams %R at -68.69. Momentum indicators show DayATR at 21.91.

Exponential moving averages include EMA5 at ₹253.1, EMA10 at ₹266.9, EMA12 at ₹273.7, EMA20 at ₹299.6. Simple moving averages include SMA5 at ₹246.6, SMA10 at ₹262.8, SMA20 at ₹299.6.

Support levels for Avience Biomedicals are placed at First Support ₹240.48, Second Support ₹229.77, Third Support ₹219.53. Resistance levels are seen at First Resistance ₹261.43, Second Resistance ₹271.67, Third Resistance ₹282.38. Avience Biomedicals Ltd. shareholding pattern shows promoter holding at 64.59%, FII holding at 3.06%, DII holding at 0%, public holding at 23.26%.

Avience Biomedicals Fundamentals

Market Cap

Below industry Median

101.30 Cr.

PE Ratio (TTM)

Below industry Median

11.60

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

12% decr over last year

27.86

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

3.20

MFI

MFI is mid-range

41.58

RSI

RSI oversold

24.57

EPS (TTM)

21.71

Debt to Equity

0.92

Face Value

Operating Profit Margin Qtr.

28.29

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

3.20

Avience Biomedicals Financials

Data not available for chart

Indicator
No Record Found

Avience Biomedicals Technicals

Avience Biomedicals Ltd. EMA & SMA

₹265.00

19.50 (7.94%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹253.1

Day EMA10 ₹266.9

Day EMA12 ₹273.7

Day EMA20 ₹299.6

Avience Biomedicals Support and Resistance

Resistance

First Resistance₹261.43

Second Resistance₹271.67

Third Resistance₹282.38

Support

First Support₹240.48

Second Support₹229.77

Third Support₹219.53

Technical Indicators

Day RSI24.57

Day MFI41.58

Day ADX-

Day Commodity Channel Index-82.50

William-68.69

Day MACD-

Day MACD Signal Line-

Day ATR21.91

Day ROC125-

Day ROC21-

Avience Biomedicals Shareholding Pattern

Held By
Promoter
FII
DII
Public

Avience Biomedicals Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	41.4 K	78.6 K	52.67%
Week	1.13 L	2.16 L	52.30%
1 Month	1.01 L	1.33 L	75.91%
6 Month	16.72 K	22.02 K	75.91%

Avience Biomedicals SWOT Analysis

Strengths10

Weakness5

Opportunity0

Threats0

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Top Gainers

Avience Biomedicals Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Avience Biomedicals Stock Comparison

Financials	Q-Line Biotech Ltd.	Gujarat Kidney and Super Speciality Ltd.	Invicta Diagnostic Ltd.	VijayPD Ceutical Ltd.	Galaxy Medicare Ltd.
Price (₹)	₹508.50	₹127.40	₹63.75	₹64	₹17.60
% Change	1.92%	0.08%	-	1.59%	0.00%
Revenue TTM (₹ Cr)	-	₹82.01	-	-	-
Net Profit TTM (₹ Cr)	-	₹15.50	-	-	-
PE TTM	20.90	64.80	17.20	24.60	7.80
1 Year Return	45.45	11.67	-21.18	80	-67.41
ROCE	26.65	8.56	13.56	14.18	-

Similar Stocks

No Data Available

FAQ's on AVIENCE

What is the Market Capitalization of Avience Biomedicals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 23 July 2026, the market cap for Avience Biomedicals Ltd. is approximately ₹ 101.3 Cr.

What are the PE and PB ratios for Avience Biomedicals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Avience Biomedicals Ltd. is 11.6, and the Price-to-Book (PB) ratio is 3.2.

What is the 52-Week High and Low for Avience Biomedicals Ltd.?

Over the past 52 weeks, the highest price reached by Avience Biomedicals Ltd. shares was ₹ 414.95, and the lowest price was ₹ 222.

Who are the major shareholders of Avience Biomedicals Ltd.?

Significant shareholdings in Avience Biomedicals Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Avience Biomedicals Ltd. in the Healthcare sector?

In the Healthcare sector, Avience Biomedicals Ltd. is often compared with other major players such as QLine Biotech, Hannah Joseph Hospital, Modern Diagnostic Research, Gujarat Kidney and Super and Park Medi World for analysis and benchmarking.